News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Serologicals Corporation (SERO) Release: Upstate Introduces Pathway Profiler Service; Offers Faster, More Complete View Of Cellular Response; Helps To Compress Drug Discovery Time


10/19/2005 5:12:32 PM

ATLANTA--(BUSINESS WIRE)--Jan. 24, 2005--Upstate Group, Inc., a Serologicals (NASDAQ: SERO) company announced today the introduction of PathwayProfiler(TM), a new service that measures cell-based signaling cascades (cell communication pathways) and provides drug development companies with a unique insight into their therapy and its efficacy in the cell. PathwayProfiler(TM) is the only service of its kind currently available.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES